⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
PBLS
REGN
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Pomerantz LLP Issues Reminder to Investors in Regeneron Pharmaceuticals, Inc. of Class Action – REGN
accessnewswire.com
REGN
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP
prnewswire.com
REGN
REGN Stockholders May Be Entitled to Lead the Class Action Lawsuit Against Regeneron Pharmaceuticals, Inc. - Contact Robbins LLP for Information About Becoming the Lead Plaintiff
globenewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
REGN DEADLINE: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
prnewswire.com
REGN
AI of Things (AIoT) Solutions Market Outlook Report 2026-2030 | Agentic AI and IoT Convergence Accelerates Autonomous Decision-Making Across Global Industries
globenewswire.com
NVDA
INTC
QCOM
MU
GOOG
CSCO
IBM
MSFT
AAPL
AMZN
ADI
TSLA
TXN
ORCL
PTC
GE
BA
HPQ
AMD
AMAT
LRCX
KLAC
ASML
META
CRM
ROK
HON
EMR
ETR
SWKS
MCHP
NXPI
ON
STM
MRVL
SNPS
CDNS
QGEN
BIIB
GILD
AMGN
REGN
VRTX
BMY
PFE
MRK
JNJ
ABBV
XOM
CVX
SRE
DUK
NEE
PCG
AEP
SO
ETSY